IGM Biosciences, Inc. (IGMS)

IGM Biosciences Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for IGM Biosciences stock have an average target of 6.14, with a low estimate of 1.50 and a high estimate of 22. The average target predicts an increase of 397.17% from the current stock price of 1.24.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.50	$6.14	$2.00	$22
Change	+21.46%	+397.17%	+61.94%	+1681.4%

* Price targets were last updated on Jan 10, 2025.

Analyst Ratings

The average analyst rating for IGM Biosciences stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	1	1	0	0	0	0
Buy	2	3	1	1	1	1
Hold	4	3	7	7	7	7
Sell	1	1	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eric Joseph JP Morgan	JP Morgan	Sell → Hold Upgrades n/a	Sell → Hold	Upgrades	n/a	n/a	Jan 13, 2025
Roger Song Jefferies	Jefferies	Strong Buy → Hold Downgrades $48 → $2	Strong Buy → Hold	Downgrades	$48 → $2	+61.94%	Jan 10, 2025
Asthika Goonewardene Truist Securities	Truist Securities	Hold Maintains $12 → $2	Hold	Maintains	$12 → $2	+61.94%	Jan 10, 2025
Stephen Willey Stifel	Stifel	Strong Buy → Hold Downgrades $27 → $2.5	Strong Buy → Hold	Downgrades	$27 → $2.5	+102.43%	Jan 10, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy → Hold Downgrades $20 → $1.5	Buy → Hold	Downgrades	$20 → $1.5	+21.46%	Jan 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

5.94M

Increased by 121.76%

from 2.68M

Revenue Next Year

8.72M

Increased by 46.83%

from 5.94M

EPS This Year

-0.98

from -3.24

EPS Next Year

-0.62

from -0.98

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	1.07M	2.13M	2.68M	5.94M	8.72M	11.32M
Revenue Growth	-	-	-	99.25%	25.78%	121.76%	46.83%	29.76%
EPS	-2.65	-4.93	-5.32	-4.71	-3.24	-0.98	-0.62	-0.85
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	25.2M	25.2M	25.2M
Avg	5.9M	8.7M	11.3M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	841.4%	324.5%	189.1%
Avg	121.8%	46.8%	29.8%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.09	-0.06	-0.04
Avg	-0.98	-0.62	-0.85
Low	-1.98	-2.24	-2.68

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.